- Home
- LBRDP vs SIGA Comparison
LBRDP vs SIGA Comparison
Compare LBRDP & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LBRDP | SIGA |
|---|---|---|
| Founded | N/A | 1995 |
| Country | United States | United States |
| Employees | 1900 | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 341.0M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | LBRDP | SIGA |
|---|---|---|
| Price | $22.00 | $4.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.8K | ★ 501.4K |
| Earning Date | N/A | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $224.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.05 | $4.10 |
| 52 Week High | $25.55 | $9.62 |
Technical Indicators
Market Signals| Indicator | LBRDP | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 47.16 | 42.58 |
| Support Level | $21.42 | $4.29 |
| Resistance Level | $22.33 | $4.84 |
| Average True Range (ATR) | 0.31 | 0.17 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 62.37 | 47.52 |
Price Performance
Historical ComparisonAbout LBRDP Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services, including video, internet, voice, and mobile services; commercial services, including small and medium business and enterprise solutions; advertising services; and other services. The company's reportable segments are GCI Holdings and Charter. The firm derives the majority of its revenue from GCI Holdings.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.